Liver stiffness measurement after success with oral antivirals predicts HCC risk, particularly among patients with advanced chronic liver disease.
Daily Times(PK) on MSN
Egypt boosts Pakistan’s fight against Hepatitis C
Egypt has donated important medicines to support Pakistan’s Hepatitis C elimination program led by Prime Minister Shehbaz ...
NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...
Patients of a Sydney dentist have been urged to get tested after they were potentially exposed to deadly-blood borne diseases ...
Gilead Sciences, Inc. (Nasdaq: GILD) will present new research that reinforces its commitment to advancing innovation for ...
A pilot scheme last year found around one in 180 patients tested had a previously undiagnosed blood-borne virus, with the rollout of the new scheme beginning in Aberdeen.
A&E patients in Aberdeen are to be the first in the country to be offered routine tests for HIV and Hepatitis B and C. The new initiative, launched on Monday, will see all patients who have a blood ...
Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...
The addition of tiragolumab to Tecentriq and Avastin did not significantly improve progression-free survival in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback